These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2217526)
1. Comparison of DuP 996, with physostigmine, THA and 3,4-DAP on hypoxia-induced amnesia in rats. DeNoble VJ; DeNoble KF; Spencer KR; Johnson LC; Cook L; Myers MJ; Scribner RM Pharmacol Biochem Behav; 1990 Aug; 36(4):957-61. PubMed ID: 2217526 [TBL] [Abstract][Full Text] [Related]
2. Protection against hypoxia-induced passive avoidance deficits: interactions between DuP 996 and ketanserin. DeNoble VJ; DeNoble KF; Spencer KR Brain Res Bull; 1991 May; 26(5):817-20. PubMed ID: 1933401 [TBL] [Abstract][Full Text] [Related]
3. Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats. Strek KF; Spencer KR; DeNoble VJ Pharmacol Biochem Behav; 1989 May; 33(1):241-4. PubMed ID: 2528749 [TBL] [Abstract][Full Text] [Related]
4. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. Yoshida S; Suzuki N Eur J Pharmacol; 1993 Nov; 250(1):117-24. PubMed ID: 8119309 [TBL] [Abstract][Full Text] [Related]
5. Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats. Ueki A; Miyoshi K J Neurol Sci; 1989 Mar; 90(1):1-21. PubMed ID: 2723670 [TBL] [Abstract][Full Text] [Related]
6. Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats. Riekkinen M; Riekkinen P Exp Neurol; 1994 Jan; 125(1):111-8. PubMed ID: 8307118 [TBL] [Abstract][Full Text] [Related]
7. Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission. Fontana DJ; Inouye GT; Johnson RM Pharmacol Biochem Behav; 1994 Dec; 49(4):1075-82. PubMed ID: 7886078 [TBL] [Abstract][Full Text] [Related]
9. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555 [TBL] [Abstract][Full Text] [Related]
10. The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats. Nabeshima T; Maruyama E; Katoh A; Kameyama T Jpn J Pharmacol; 1991 Nov; 57(3):311-9. PubMed ID: 1813659 [TBL] [Abstract][Full Text] [Related]
11. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P Pharmacol Biochem Behav; 1991 Aug; 39(4):841-6. PubMed ID: 1763101 [TBL] [Abstract][Full Text] [Related]
12. Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion. Riekkinen P; Riekkinen M; Lahtinen H; Sirviö J; Valjakka A; Riekkinen P Brain Res Bull; 1991 Nov; 27(5):587-94. PubMed ID: 1756376 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the cholinergic neuronal system and benzodiazepine receptors in alcohol-induced amnesia. Nabeshima T; Tohyama K; Ishihara S; Kameyama T Eur J Pharmacol; 1991 Mar; 195(2):285-9. PubMed ID: 1651866 [TBL] [Abstract][Full Text] [Related]
14. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. Xiao WB; Nordberg A; Zhang X J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822 [TBL] [Abstract][Full Text] [Related]
15. Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats. Murray TK; Cross AJ; Green AR Psychopharmacology (Berl); 1991; 105(1):134-6. PubMed ID: 1745706 [TBL] [Abstract][Full Text] [Related]
16. Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice. Nabeshima T; Yoshida S; Kameyama T Eur J Pharmacol; 1988 Sep; 154(3):263-9. PubMed ID: 3234481 [TBL] [Abstract][Full Text] [Related]
17. Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats. Aaltonen M; Riekkinen P; Sirviö J; Riekkinen P Pharmacol Biochem Behav; 1991 Jul; 39(3):563-7. PubMed ID: 1784585 [TBL] [Abstract][Full Text] [Related]
18. Tetrahydroaminoacridine, 3,4 diaminopyridine and physostigmine: direct comparison of effects on memory in aged primates. Bartus RT; Dean RL Neurobiol Aging; 1988; 9(4):351-6. PubMed ID: 3185853 [TBL] [Abstract][Full Text] [Related]
19. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models. Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804 [TBL] [Abstract][Full Text] [Related]
20. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat. Bassant MH; Jazat F; Lamour Y J Cereb Blood Flow Metab; 1993 Sep; 13(5):855-64. PubMed ID: 8360291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]